09-0790
Ethanol (denatured)
94.8-95.8%, JIS special grade
Sinónimos:
Alcohol etílico
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
Acerca de este artículo
Fórmula lineal:
CH3CH2OH
Número CAS:
Peso molecular:
46.07
PubChem Substance ID:
UNSPSC Code:
15101802
EC Number:
200-578-6
MDL number:
Beilstein/REAXYS Number:
1718733
Assay:
94.8-95.8%
Grade:
JIS special grade
Bp:
78 °C (lit.)
Vapor pressure:
44.6 mmHg ( 20 °C)
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleNombre del producto
Etanol, JIS special grade, 94.8-95.8%
grade
JIS special grade
vapor density
1.59 (vs air)
vapor pressure
44.6 mmHg ( 20 °C)
assay
94.8-95.8%
form
liquid
autoignition temp.
683 °F
expl. lim.
19 %, 60 °F
availability
available only in Japan
dilution
(for analytical testing)
refractive index
n20/D 1.3600 (lit.)
pH
7.0 (20 °C, 10 g/L)
bp
78 °C (lit.)
mp
−114 °C (lit.)
format
neat
SMILES string
CCO
InChI
1S/C2H6O/c1-2-3/h3H,2H2,1H3
InChI key
LFQSCWFLJHTTHZ-UHFFFAOYSA-N
Other Notes
1La distribución y el uso del alcohol etílico en Suiza requiere una autorización de la Swiss Federal Alcohol Administration
Still not finding the right product?
Explore all of our products under Etanol
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2
Clase de almacenamiento
3 - Flammable liquids
wgk
WGK 1
flash_point_f
55.4 °F - closed cup
flash_point_c
13 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Ross B Mounsey et al.
Experimental neurology, 273, 36-44 (2015-08-06)
Parkinson's disease (PD) is a common chronic neurodegenerative disorder, usually of idiopathic origin. Symptoms including tremor, bradykinesia, rigidity and postural instability are caused by the progressive loss of dopaminergic neurons in the nigrostriatal region of the brain. Symptomatic therapies are
Cem Kuscu et al.
Nature biotechnology, 32(7), 677-683 (2014-05-20)
RNA-guided genome editing with the CRISPR-Cas9 system has great potential for basic and clinical research, but the determinants of targeting specificity and the extent of off-target cleavage remain insufficiently understood. Using chromatin immunoprecipitation and high-throughput sequencing (ChIP-seq), we mapped genome-wide
Stefan Wieland et al.
Hepatology (Baltimore, Md.), 59(6), 2121-2130 (2013-10-15)
Approximately 50% of patients with chronic hepatitis C (CHC) have ongoing expression of interferon stimulated genes (ISGs) in the liver. It is unclear why this endogenous antiviral response is inefficient in eradicating the infection. Several viral escape strategies have been